The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
P15 Methylation [Meth] and Expression and the Development of the Secondary Hematologic Disorders.
 
Fang-Shu Ou
No Relationships to Disclose
 
Yiyue Lou
No Relationships to Disclose
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I)
Research Funding - Taiho Pharmaceutical
 
Hans-Joachim Schmoll
Honoraria - Roche, GSK, Servier
Consulting or Advisory Role - Roche, Bayer, GSK
Research Funding - Roche, GSK
Travel, Accommodations, Expenses - Roche; Bayer, Servier; GSK
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; kanghong Pharma; Merck; Merck KGaA; Merrimack; Pfizer; Taiho Pharmaceutical; Targovax
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi
 
Paulo Hoff
No Relationships to Disclose
 
Jean-Yves Douillard
No Relationships to Disclose
 
J. Randolph Hecht
No Relationships to Disclose
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
 
Cornelis J. A. Punt
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Nordic Bioscience; Roche
 
Carsten Bokemeyer
Honoraria - Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Hexal; Lilly/ImClone; Merck Serono; Mundipharma; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pfizer; Sanofi
 
Charles S. Fuchs
Consulting or Advisory Role - Agios; Bayer; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Sanofi; Taiho Pharmaceutical
 
Eduardo Diaz-Rubio
Consulting or Advisory Role - AMGEN; BAYER; GENOMICA; Merck Serono; MSD; Roche
Speakers' Bureau - MSD; SERVIER
Research Funding - AMGEN; AstraZeneca (Inst); Merck Serono (Inst); ROCHE (Inst)
 
Niall Tebbut
No Relationships to Disclose
 
Alfredo Falcone
Honoraria - Lilly, Roche, Merck, Servier, Celgene
Consulting or Advisory Role - Amgen, Bayer, Bristol, Lilly, Merck, Roche, Sanofi, Servier
Research Funding - Amgen, Bayer, Merck, Roche, Sanofi, MSD, Servier (Inst)
 
Fairooz F. Kabbinavar
No Relationships to Disclose
 
Aimery De Gramont
Honoraria - Chugai Pharma; Yakult Pharmaceutical
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme
 
Qian Shi
No Relationships to Disclose